MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.metabol.2018.09.004

Медицинская библиотека · Metabolism: clinical and experimental · 2018

Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.

Liu Limei, Liu Yanjun, Ge Xiaoxu, Liu Xipeng, Chen Chen, Wang Yanzhong, Li Ming, Yin Jun, Zhang Juan, Chen Yating, Zhang Rong, Jiang Yanyan, Zhao Weijing, Yang Di, Zheng Taishan, Lu Ming, Zhuang Langen, Jiang Meisheng

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Heterozygous inactivating mutations in GCK are associated with defects in pancreatic insulin secretion and/or hepatic glycogen synthesis leading to mild chronic hyperglycaemia of maturity onset diabetes of young type 2 (MODY2). However, the effect of naturally occurring GCK mutations on the pathogenesis for MODY2 hyperglycaemia remains largely unclear, especially in the Asian population. The aim of this study is to explore the potential pathogenicity of novel GCK mutations related to MODY2.

METHODS

Genetic screening for GCK mutations from 96 classical MODY families was performed, and structure-function characterization and clinical profile of identified GCK mutations were conducted.

RESULTS

Five novel (F195S, I211T, V222D, E236G and K458R) and five known (T49N, I159V, R186X, A188T and M381T) mutations were identified and co-segregated with hyperglycaemia in their pedigrees. R186X generates non-functional truncated form and V222D and E236G fully inactivate glucokinase due to severe structure disruptions. The other seven GCK mutations exhibited marked reductions in catalytic efficiency and thermo-stability; notably, the interaction with GKRP was significantly enhanced in I211T, I159V, T49N and K458R, reduced in F195S and M381T, and completely lost with A188T. 31% (17/55) of MODY2 patients showed signs of insulin resistance. Conventional hypoglycaemia treatment did not improve the HbA1C in MODY2 patients when insulin resistance is not present.

CONCLUSIONS

Five novel GCK mutations have been identified in Chinese MODY. The defects in enzymatic activity and protein stability, together with alteration of GKRP binding on GCK mutants may synergistically contribute to the development of MODY2 hyperglycaemia. No treatment should be prescribed to MODY2 patients when insulin resistance is not present.

Для цитирования: Liu Limei, Liu Yanjun, Ge Xiaoxu, Liu Xipeng, Chen Chen, Wang Yanzhong, Li Ming, Yin Jun, Zhang Juan, Chen Yating, Zhang Rong, Jiang Yanyan, Zhao Weijing, Yang Di, Zheng Taishan, Lu Ming, Zhuang Langen, Jiang Meisheng. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.. Metabolism: clinical and experimental. 2018. DOI: 10.1016/j.metabol.2018.09.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.